Objective COVID-19 disproportionately impacts residents in long-term care facilities. Our
objective was to quantify the presence and magnitude of antibody response in vaccinated …

Background Nursing home (NH) residents suffered the greatest impact of the COVID-19
pandemic. Limited data are available on vaccine-induced immunity and on the protection …

Methods In this serial cross-sectional analysis, we examined SARS-CoV-2 neutralizing
antibody titers after both second and third vaccination in nursing home residents, and after …

Importance West Virginia prioritized SARS-CoV-2 vaccine delivery to nursing home facilities
because of increased risk of severe illness in elderly populations. However, the persistence …

Background The magnitude and durability of immune responses to coronavirus disease
2019 (COVID-19) mRNA vaccines remain incompletely characterized in the elderly …

Background: Although the SARS-CoV2 mRNA vaccines have proven high efficacy in clinical
trials, there is limited data on the impact of age, sex, and side effects on vaccine-induced …

Background Older age is associated with poorer outcomes to COVID-19 infection. The
Norwegian Institute of Public Health established a longitudinal cohort of adults aged 65–80 …

Background Third coronavirus disease 2019 (COVID-19) vaccine doses are broadly
recommended, but immunogenicity data remain limited, particularly in older adults. Methods …

Importance Head-to-head safety comparisons of the mRNA vaccines for SARS-CoV-2 are
needed for decision making; however, current evidence generalizes poorly to older adults …

Background Testing of vaccine candidates to prevent infection with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased …